A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis
Lists
Only you see this
BibTeX
@misc{chen2022randomized,
author = {Yu Chen and Gang Wang and Furen Zhang and Yangfeng Ding and Yumei Li and Yi Zhao and Jun Gu and Shuping Guo and Weili Pan and Hongzhong Jin and Qing Sun and Xiaojing Kang and Qinping Yang and Xian Jiang and Zhiqiang Song and Qianjin Lu and Xiaowen Pang and Yehong Kuang and Danqi Deng and Yuzhen Li and Chunlei Zhang and Juan Tao and Liangzhi Xie and Yan Wang and Jieying Wang},
title = {{A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis}},
year = {2022},
doi = {10.2139/ssrn.4125006},
howpublished = {SSRN},
}Loading related content...